Improper AQP9 expression promotes chronic liver injury (CLI), which is a common disease resulting in hepatic steatosis, liver fibrosis, and eventually, if not treated, hepatocellular carcinoma (HCC) [217]. This evidence concerns the gene AQP9 and hepatocellular carcinoma.